心脏性休克:临床试验者面临的一个重大挑战
Dhruv Sarma1, Jacob C Jentzer2, Sabri Soussi3,4
1Department of Internal Medicine, Mayo Clinic Rochester.
Current opinion in critical care
|June 20, 2023
概括
改善心脏性休克 (CS) 临床试验对于开发有效治疗方法至关重要. 通过精确的定义,患者选择和生物标志物丰富来优化试验设计,可以带来个性化的医学方法,以获得更好的结果.
科学领域:
- 心脏病学 心脏病学
- 临床试验 临床试验
- 翻译医学是一种翻译医学.
背景情况:
- 心脏性休克 (CS) 与高死亡率和有限的基于证据的疗法有关.
- 对新型CS干预措施的众多临床试验尽管有前临床数据很有希望,但却产生了中立的结果.
研究的目的:
- 审查对心脏性休克进行临床试验的挑战.
- 提出优化和协调未来CS试验设计的策略.
主要方法:
- 分析CS临床试验中常见的陷,包括招生问题,患者队列异质性和结果报告.
- 讨论必要的改进,如精确的CS定义,严重程度分阶段,增强知情同意和以患者为中心的结果.
- 探索使用宿主反应生物标志物进行预测性丰富,用于个性化医学.
主要成果:
- CS试验往往受到缓慢招生,非代表性患者群体和不确定的结果的影响.
- 关键的改进包括准确的CS定义,实用性的严重程度分阶段,更好的知情同意和以患者为中心的结果.
- 生物标志物分层的适应性设计可以解决异质性,并确定可能从特定治疗中受益的患者子组.
结论:
- 解决试验设计挑战对于推进CS治疗至关重要.
- 以生物标志物和亚表型为指导的个性化医疗方法,有望改善心脏性休克的结果.
- 生物标志物分层的适应性试验设计为CS的更有洞察力和更有效的临床研究提供了一条道路.
相关概念视频
Blood Pressure Imbalances and Circulatory Shock
819
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
819
Cardiomyopathy II: Dilated Cardiomyopathy
12
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
12
Cardiopulmonary Resuscitation IV: Pharmacological Management
29
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
29
Heart Failure III: Clinical Manifestations
25
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
25
Cardiomyopathy V: Interprofessional Care
18
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
18
Heart Failure II: Pathophysiology
16
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16


